Now I have enough information to calibrate. Let me write the final review.

**Calibration summary:**

**Round-1 bracket**: Initially bracketed across topic and weakness queries. Low-band topic anchors (scMPT 3.40, Weighted Diversified Sampling 3.00) and mid-band (GenoAgent 4.00, ZerOmics 4.67, BioDiscoveryAgent 6.40). Weakness-anchored queries returned scores from 3.50 to 5.75 for papers with similar evaluation gaps.

**Round-2 narrowing**: Focused on (3.0, 5.5) range. Key comparables: GenoAgent (4.00, Reject), ZerOmics (4.67, Reject), scMPT (3.40, Reject), SUMMER (4.60, Accept).

**What low-band anchors failed at**: scMPT (3.40) lacked depth — bundled surface-level analyses. The HypoGeneAgent paper has substantially more depth in its Stage 1 LLM benchmarking, but shares with both low- and mid-band papers a critical evaluation gap: the central claim (biologically superior resolution selection) is not validated against any external biological ground truth. Papers with this failure mode consistently scored ≤4.33.

**Final score**: 3.5. Paper has genuine novelty and solid LLM benchmarking, but the main claim is unsupported, and the enrichment baseline comparison is flawed. These gaps are structural, not cosmetic.

---

## Summary

HypoGeneAgent proposes an LLM-driven framework that uses the consistency and distinctiveness of GPT-o3–generated Gene Ontology hypotheses to select the clustering resolution in single-cell and Perturb-seq analyses. After clustering at multiple Leiden resolutions, an LLM generates ranked GO-based annotations for each cluster; the intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) of these annotations are combined into a Resolution Score (RS), with the optimal resolution maximizing RS. The method is applied to a K562 CRISPRi Perturb-seq dataset and compared qualitatively with silhouette score, modularity, and functional enrichment analysis. Stage 1 benchmarks provide a thorough comparison of LLMs, prompt designs, and embedding methods on curated GOBP gene sets.

## Strengths

- **Novel formulation of biology-aware resolution selection.** Defining a Resolution Score from LLM-generated annotation consistency (ICS + ICD) is a genuinely creative approach to a real problem — unsupervised clustering currently lacks a principled, biology-aware criterion for choosing resolution. The formalization in Section 3.4 is clean, and Figures 3–4 demonstrate that the RS produces a clear optimum (r=0.4 for GEX, r=0.5 for perturbation) whose components independently support the same choice.

- **Systematic Stage 1 LLM benchmarking.** The paper provides a thorough comparison of embedding methods (OpenAI, SapBERT, Nomic), prompt designs (general vs. hypothesis), temperature, and LLM backends (GPT-4o, GPT-o3, GPT-5, Gemini) on 100 curated GOBP sets. The finding that thinking LLMs (GPT-o3) with hypothesis prompts outperform non-thinking models, and that GPT-o3's confidence scores correlate with semantic similarity to ground truth (Figures S1–S3), is a useful methodological contribution that goes beyond what prior gene-set annotation work has reported.

## Weaknesses

### Fatal
None.

### Major

- **The central claim — that the Resolution Score selects biologically superior resolutions — is unsupported by the evidence presented.** The paper claims that HypoGeneAgent "selects clustering granularities that exhibit alignment with known pathway compared to classical metrics" (abstract) and that the RS recovers "known perturbation effects better than modularity and silhouette criteria" (Introduction, §1). However, the evaluation never measures cluster quality against any independent biological ground truth (e.g., known cell types, known perturbation-phenotype associations, curated pathway databases, or held-out experimental labels). The RS is defined from LLM outputs, and showing that it has a clear optimum does not constitute evidence that this optimum is biologically meaningful. The comparisons to silhouette (elbow at 0.5/0.6) and modularity (peak at 0.7) are purely visual/qualitative — they show that the RS optimum *differs* from traditional metrics, but not that it is *better*. Without an external biological quality metric evaluated at every resolution, the paper's central comparative claim cannot be sustained.

- **The functional-enrichment baseline comparison is improperly handled and undermines the validation argument.** The authors compute ICS/ICD analogues from standard GO enrichment results (Figure 6), and the resulting enrichment-based RS peaks at resolution 0.7 (confirmed by the figure caption: "resolution score peaks at 0.7"). The authors then override this quantitative result by stating "consider the reasonability of cluster numbers we expected, so the selected resolution can be 0.5 or 0.4, which is consistent with our previous selection." This post-hoc adjustment to match the HypoGeneAgent result invalidates the enrichment analysis as an independent validation. Additionally, the paper does not specify how ICS/ICD metrics are computed from enrichment p-values (which lack the free-text hypothesis structure that the cosine-similarity pipeline is designed for), making the comparison uninterpretable.

- **Single-dataset evaluation with overclaimed generalizability.** The full Stage 2 pipeline is demonstrated on only one dataset (K562 Perturb-seq, Replogle et al. 2022). Claims that the approach "readily extends to multi-omics modalities" and that the w=1/3 weighting "was found to give a stable ordering of resolutions across data sets" (Section 3.4) are unsupported — a single dataset cannot demonstrate either generalizability or stability. At minimum, a second independent dataset (e.g., a PBMC scRNA-seq with known cell types or a different Perturb-seq experiment) is needed to assess the method's transferability.

### Minor

- **The w=1/3 weight choice and its stability are not properly characterized.** The paper states that w=1/3 "was chosen by a small grid search and found to give a stable ordering of resolutions across data sets" (Section 3.4), but with only one dataset, "across datasets" is unsubstantiated. The w-sensitivity test (Figure S5) is mentioned but not analyzed in the main text. Showing how the optimal resolution changes as a function of w across the full [0,1] range would clarify the method's robustness.

- **The enrichment baseline methodology is underspecified.** The paper says it applies "the similar metrics raised for HypoGeneAgent on these enrichment results" but never explains how GO enrichment p-values or lists of significant terms are converted into the ICS/ICD cosine-similarity framework designed for free-text LLM hypotheses. This makes Figure 6 impossible to interpret or reproduce.

- **No sensitivity analysis for H=5 hypotheses.** The method fixes the number of hypotheses at H=5, but the impact of this choice on RS stability is not examined (e.g., H=3 or H=10).

- **Computational cost is not reported.** For a method requiring ~200+ GPT-o3 API calls per dataset, practical adoption hinges on cost. No runtime or cost estimates are provided.

### Trivial

- The paper states that the enrichment-based RS "validates that the clusters produced at the Resolution Score maximum are biologically coherent" (Section 4.4.3), but the figure itself shows the enrichment-based RS peaking at 0.7, not at 0.4/0.5 — this internal contradiction is confusing.
- Figure references in the text to supplemental figures (S1–S6) are not always aligned with the inline discussion.

## Nice-to-Haves

- Replace the qualitative comparison with traditional metrics by defining an external biological quality metric (e.g., enrichment of known pathway gene sets, purity with respect to known perturbation groups, or consistency with curated cell-type markers) and showing that the RS optimum maximizes this metric relative to silhouette/modularity optima.
- Test on at least one additional independent dataset (even a small scRNA-seq with known cell-type labels) to demonstrate transferability.
- Perform a systematic w-sensitivity analysis showing which resolution each w value selects.
- Provide expert evaluation of a sample of the LLM-generated GO annotations at the selected resolution to ground the claim that the LLM produces biologically accurate hypotheses for real Perturb-seq clusters.

## Removed Points

1. **Strength Finder claim that enrichment analysis "validates" the agent's results** — Removed because the enrichment-based RS actually peaks at 0.7 (not 0.4/0.5), and the paper overrides this quantitative result. This putative strength depends on the paper's own contested reasoning rather than independent evidence.

2. **Harsh critic's claim about "circularity" (RS is maximized by construction)** — Demoted from potential Fatal to subsumed under the first Major weakness. The RS definition is not circular as a methodology; the circularity concern applies to the *evaluation* (claiming biological validity from the RS optimum without external validation), which is already captured.

3. **Concerns about "the paper already acknowledges limitations but doesn't resolve them"** — Not a weakness per se; acknowledgment without resolution is standard practice. The limitations (scalability, generalizability, cost) are honestly stated in the conclusion.

4. **Critique about "no independent biological quality metric" as a standalone weakness** — Merged into the first Major weakness (central claim unsupported), which covers this comprehensively.

## Novel Insights

None beyond the paper's own contributions — the reviews surface the core evaluation gap but do not provide independent conceptual insights beyond what the paper's framing already captures.

## Suggestions

1. **Reframe the paper as a proof-of-concept / methodology paper** rather than claiming validated superiority. The idea of using LLM annotation consistency for resolution selection is novel enough to stand on its own as a methodological contribution, without needing to claim that RS outperforms traditional metrics. Adjust the abstract and conclusion accordingly.

2. **Add an external validation experiment** as the highest-priority revision. Define a set of known biological relationships in the K562 data (e.g., KEGG pathways from Replogle et al., hierarchical GO terms, or expert-curated perturbation groups), compute a "biological coherence score" at each resolution that does not use the LLM (e.g., mean enrichment p-value of known pathway genes in each cluster), and show that the RS optimum aligns with this external measure.

3. **Correct or remove the enrichment baseline comparison.** Either specify the methodology clearly and report the quantitative result honestly without overriding it, or remove this comparison entirely and replace it with a properly designed external validation.

4. **Add a second dataset** (small scRNA-seq with known cell-type labels, e.g., a PBMC dataset) to demonstrate that the approach generalizes.

## Score and Decision

MY FINAL SCORE: <score>3.5</score>
MY FINAL DECISION: <decision>Reject</decision>